AII
TPTX

AGF Investments Inc’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

AGF Investments Inc’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-88
Closed -$6K – 799
2021
Q3 		$6K Hold
88
– – ﹤0.01% 710
2021
Q2 		$7K Buy
88
+29
+49% +$2.14K ﹤0.01% 710
2021
Q1 		$6K Buy
+59
New +$7.02K ﹤0.01% 723

Other funds holding TPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

AGF Investments Inc's TPTX Position: Q4 2021 in Review

AGF Investments Inc sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 88 shares — an estimated $6K sold.

AGF Investments Inc first reported a position in TPTX in Q1 2021 and held it in 3 quarters. The position peaked at $7K in Q2 2021. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

  • AGF Investments Inc reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • AGF Investments Inc sold 88 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $6K.
  • AGF Investments Inc first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • AGF Investments Inc's Turning Point Therapeutics, Inc. Common Stock position peaked at $7K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on AGF Investments Inc's 13F filing for Q4 2021, filed 1 Feb 2022.